BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

504 related articles for article (PubMed ID: 14732626)

  • 21. [Evaluation of a simplified maintenance of wakefulness test for the diagnosis of daytime sleepiness].
    Luo YM; Zhong NS
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Dec; 27(12):847-9. PubMed ID: 15730787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sleep episodes and daytime somnolence as result of individual susceptibility to different dopaminergic drugs in a PD patient: a polysomnographic study.
    Romigi A; Brusa L; Marciani MG; Pierantozzi M; Placidi F; Izzi F; Sperli F; Testa F; Stanzione P
    J Neurol Sci; 2005 Jan; 228(1):7-10. PubMed ID: 15607203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine agonists and sleepiness in PD: review of the literature and personal findings.
    Manni R; Terzaghi M; Sartori I; Mancini F; Pacchetti C
    Sleep Med; 2004 Mar; 5(2):189-93. PubMed ID: 15033142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial.
    Holloway RG; Shoulson I; Fahn S; Kieburtz K; Lang A; Marek K; McDermott M; Seibyl J; Weiner W; Musch B; Kamp C; Welsh M; Shinaman A; Pahwa R; Barclay L; Hubble J; LeWitt P; Miyasaki J; Suchowersky O; Stacy M; Russell DS; Ford B; Hammerstad J; Riley D; Standaert D; Wooten F; Factor S; Jankovic J; Atassi F; Kurlan R; Panisset M; Rajput A; Rodnitzky R; Shults C; Petsinger G; Waters C; Pfeiffer R; Biglan K; Borchert L; Montgomery A; Sutherland L; Weeks C; DeAngelis M; Sime E; Wood S; Pantella C; Harrigan M; Fussell B; Dillon S; Alexander-Brown B; Rainey P; Tennis M; Rost-Ruffner E; Brown D; Evans S; Berry D; Hall J; Shirley T; Dobson J; Fontaine D; Pfeiffer B; Brocht A; Bennett S; Daigneault S; Hodgeman K; O'Connell C; Ross T; Richard K; Watts A;
    Arch Neurol; 2004 Jul; 61(7):1044-53. PubMed ID: 15262734
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of armodafinil in the treatment of residual excessive sleepiness associated with obstructive sleep apnea/hypopnea syndrome: a 12-week, multicenter, double-blind, randomized, placebo-controlled study in nCPAP-adherent adults.
    Roth T; White D; Schmidt-Nowara W; Wesnes KA; Niebler G; Arora S; Black J
    Clin Ther; 2006 May; 28(5):689-706. PubMed ID: 16861091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excessive Daytime sleepiness in idiopathic restless legs syndrome: characteristics and evolution under dopaminergic treatment.
    Kallweit U; Siccoli MM; Poryazova R; Werth E; Bassetti CL
    Eur Neurol; 2009; 62(3):176-9. PubMed ID: 19602890
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influence of the nonergot dopamine agonist piribedil on vigilance in patients With Parkinson Disease and excessive daytime sleepiness (PiViCog-PD): an 11-week randomized comparison trial against pramipexole and ropinirole.
    Eggert K; Öhlwein C; Kassubek J; Wolz M; Kupsch A; Ceballos-Baumann A; Ehret R; Polzer U; Klostermann F; Schwarz J; Fuchs G; Jost W; Albert A; Haag A; Hermsen A; Lohmüller K; Kuhn K; Wangemann M; Oertel WH;
    Clin Neuropharmacol; 2014; 37(4):116-22. PubMed ID: 24992083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects.
    Lyons KE; Friedman JH; Hermanowicz N; Isaacson SH; Hauser RA; Hersh BP; Silver DE; Tetrud JW; Elmer LW; Parashos SA; Struck LK; Lew MF; Pahwa R
    Clin Neuropharmacol; 2010; 33(1):5-10. PubMed ID: 19855267
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Excessive daytime sleepiness in adults with brain injuries.
    Masel BE; Scheibel RS; Kimbark T; Kuna ST
    Arch Phys Med Rehabil; 2001 Nov; 82(11):1526-32. PubMed ID: 11689971
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Excessive daytime sleepiness in de novo and treated Parkinson's disease.
    Fabbrini G; Barbanti P; Aurilia C; Vanacore N; Pauletti C; Meco G
    Mov Disord; 2002 Sep; 17(5):1026-30. PubMed ID: 12360553
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conversion from dopamine agonists to cabergoline: an open-label trial in 128 patients with advanced Parkinson disease.
    Linazasoro G;
    Clin Neuropharmacol; 2008; 31(1):19-24. PubMed ID: 18303487
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Valvular heart disease in Parkinson's disease treated with ergot derivative dopamine agonists.
    Kim JY; Chung EJ; Park SW; Lee WY
    Mov Disord; 2006 Aug; 21(8):1261-4. PubMed ID: 16685692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sleep and sleepiness in patients with Parkinson's disease before and after dopaminergic treatment.
    Kaynak D; Kiziltan G; Kaynak H; Benbir G; Uysal O
    Eur J Neurol; 2005 Mar; 12(3):199-207. PubMed ID: 15693809
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vigilance troubles in Parkinson's disease: a subjective and objective polysomnographic study.
    Monaca C; Duhamel A; Jacquesson JM; Ozsancak C; Destée A; Guieu JD; Defebvre L; Derambure P
    Sleep Med; 2006 Aug; 7(5):448-53. PubMed ID: 16740409
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind, single-dose, cross-over study of the effects of pramipexole, pergolide, and placebo on rest tremor and UPDRS part III in Parkinson's disease.
    Navan P; Findley LJ; Jeffs JA; Pearce RK; Bain PG
    Mov Disord; 2003 Feb; 18(2):176-80. PubMed ID: 12539211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A study of excessive daytime sleepiness and its clinical significance in three groups of Parkinson's disease patients taking pramipexole, cabergoline and levodopa mono and combination therapy.
    Pal S; Bhattacharya KF; Agapito C; Chaudhuri KR
    J Neural Transm (Vienna); 2001; 108(1):71-7. PubMed ID: 11261748
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nighttime sleep problems and daytime sleepiness in Parkinson's disease.
    Verbaan D; van Rooden SM; Visser M; Marinus J; van Hilten JJ
    Mov Disord; 2008 Jan; 23(1):35-41. PubMed ID: 17960797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sleep quality and daytime sleepiness in schizophrenia spectrum disorders during antipsychotic treatment].
    Wichniak A; Waliniowska E; Wierzbicka A; Czasak K; Musińska I; Szatkowska E; Jernajczyk W; Jarema M
    Psychiatr Pol; 2009; 43(2):193-202. PubMed ID: 19697789
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Excessive daytime sleepiness in Parkinson's disease: characteristics and determinants.
    Poryazova R; Benninger D; Waldvogel D; Bassetti CL
    Eur Neurol; 2010; 63(3):129-35. PubMed ID: 20090346
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Predictors of sudden onset of sleep in Parkinson's disease.
    Körner Y; Meindorfner C; Möller JC; Stiasny-Kolster K; Haja D; Cassel W; Oertel WH; Krüger HP
    Mov Disord; 2004 Nov; 19(11):1298-305. PubMed ID: 15389999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.